Back
Day Range
$727.97
$743.17
52-Week Range
$476.49
$821.11
Volume
507,714
50D / 200D Avg
$766.57
/
$651.78
Prev Close
$736.53
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 17.1 | 0.3 |
| P/B | 2.5 | 2.9 |
| ROE % | 14.9 | 3.7 |
| Net Margin % | 31.4 | 3.8 |
| Rev Growth 5Y % | -2.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$862.74
+16.3%
Low: $700.00
High: $1,057.00
Forward P/E
16.2
Forward EPS
$45.38
EPS Growth (est.)
+0.0%
Est. Revenue
16 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$71.97
$64.90 – $79.90
|
21 B | 2 |
| FY2029 |
$67.38
$60.76 – $74.80
|
20 B | 4 |
| FY2028 |
$60.83
$48.91 – $72.26
|
19 B | 6 |
Key Takeaways
Revenue declined -2.81% annually over 5 years
ROE of 14.87% — decent returns on equity
Net margin of 31.41% shows strong profitability
Debt/Equity of 0.09 — conservative balance sheet
Generating 4.08B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.80%
Growth
Revenue Growth (5Y)
-2.81%
Revenue (1Y)0.99%
Earnings (1Y)2.09%
FCF Growth (3Y)5.48%
Quality
Return on Equity
14.87%
ROIC7.90%
Net Margin31.41%
Op. Margin24.95%
Safety
Debt / Equity
0.09
Current Ratio4.13
Interest Coverage81.69
Valuation
P/E Ratio
17.11
P/B Ratio2.47
EV/EBITDA21.42
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.99% | Revenue Growth (3Y) | 4.57% |
| Earnings Growth (1Y) | 2.09% | Earnings Growth (3Y) | 6.74% |
| Revenue Growth (5Y) | -2.81% | Earnings Growth (5Y) | -13.58% |
| Profitability | |||
| Revenue (TTM) | 14.34B | Net Income (TTM) | 4.50B |
| ROE | 14.87% | ROA | 11.11% |
| Gross Margin | 85.35% | Operating Margin | 24.95% |
| Net Margin | 31.41% | Free Cash Flow (TTM) | 4.08B |
| ROIC | 7.90% | FCF Growth (3Y) | 5.48% |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 4.13 |
| Interest Coverage | 81.69 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 17.11 | P/B Ratio | 2.47 |
| P/S Ratio | 5.37 | PEG Ratio | 3.38 |
| EV/EBITDA | 21.42 | Dividend Yield | 0.00% |
| Market Cap | 77.06B | Enterprise Value | 76.65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.34B | 14.20B | 13.12B | 12.17B | 16.07B |
| Net Income | 4.50B | 4.41B | 3.95B | 4.34B | 8.08B |
| EPS (Diluted) | 41.48 | 38.34 | 34.77 | 38.22 | 71.97 |
| Gross Profit | 12.24B | 12.23B | 10.87B | 10.47B | 13.35B |
| Operating Income | 3.58B | 3.99B | 4.35B | 5.39B | 8.95B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40.56B | 37.76B | 33.08B | 29.21B | 25.43B |
| Total Liabilities | 9.30B | 8.41B | 7.11B | 6.55B | 6.67B |
| Shareholders' Equity | 31.26B | 29.35B | 25.97B | 22.66B | 18.77B |
| Total Debt | 2.71B | 2.70B | 2.70B | 2.70B | 2.70B |
| Cash & Equivalents | 3.12B | 2.49B | 2.73B | 3.11B | 2.89B |
| Current Assets | 18.02B | 18.66B | 19.48B | 15.88B | 14.01B |
| Current Liabilities | 4.37B | 3.94B | 3.42B | 3.14B | 3.93B |